Schirmer RH et al., 2011-02-12: Review of methylene blue's 120-year medical history, calling it the first synthetic drug and covering its antimalarial use and later neurodegenerative research.
Methylene blue (MB), the first synthetic drug, has a 120-year-long history of diverse applications, both in medical treatments and as a staining reagent.
Schirmer RH et al., 2011-02-12: Review of methylene blue's 120-year medical history, calling it the first synthetic drug and covering its antimalarial use and later neurodegenerative research. C13/C11 Schirmer 2011. Study type: narrative review. Country: Germany (University of Heidelberg). Funder/conflicts: not in the record. Records the historical claim ('first synthetic drug') with a citation trail; the abstract contains no comparison with hydroxychloroquine, so it supports the history the comparison rests on and not the comparison itself. Also filed as MTP-01 (claims C1, C13). Study type: review.
